MDLN
Medline Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$31.64
−1.49%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- $0.34
- Revenue estimate
- $7.7B
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- $0.50
- EPS estimate
- $0.35
- Revenue actual
- $7.7B
- Revenue estimate
- $7.5B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -16.8%
- Revenue beats (12Q)
- 3
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $46
- PT range
- $34 – $55
- Analysts
- 9
8 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | $0.35 | $0.50 | Beat 41.88% | $7.7B |
| May 6, 2026 | $0.30 | $0.33 | Beat 11.79% | $7.4B |
| Feb 25, 2026 | $0.24 | -$0.01 | Miss -104.20% | $7.8B |
| Nov 4, 2025 | — | $0.31 | — | $7.1B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026